A detailed history of Blackhawk Capital Partners Llc. transactions in Pfizer Inc stock. As of the latest transaction made, Blackhawk Capital Partners Llc. holds 28,882 shares of PFE stock, worth $824,003. This represents 0.49% of its overall portfolio holdings.

Number of Shares
28,882
Previous 32,332 10.67%
Holding current value
$824,003
Previous $897,000 9.92%
% of portfolio
0.49%
Previous 0.57%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$25.26 - $29.6 $87,147 - $102,120
-3,450 Reduced 10.67%
28,882 $808,000
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $837,075 - $961,230
32,332 New
32,332 $897,000
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $735,406 - $859,616
-22,917 Reduced 58.84%
16,033 $531,000
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $70,867 - $81,991
1,962 Added 5.3%
38,950 $1.43 Million
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $1.46 Million - $1.9 Million
36,988 New
36,988 $1.51 Million
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $1.57 Million - $2.04 Million
-48,472 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $59,094 - $66,348
1,598 Added 3.41%
48,472 $2.1 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $101,325 - $111,322
2,702 Added 6.12%
46,874 $1.99 Million
Q4 2018

Feb 04, 2019

BUY
$38.47 - $43.86 $20,466 - $23,333
532 Added 1.22%
44,172 $1.93 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $525,633 - $637,560
15,249 Added 53.71%
43,640 $1.92 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $851,576 - $907,866
25,821 Added 1004.71%
28,391 $1.03 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $9,477 - $10,994
-297 Reduced 10.36%
2,570 $91,000
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $95,356 - $101,176
2,867
2,867 $104,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Blackhawk Capital Partners Llc. Portfolio

Follow Blackhawk Capital Partners Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

News

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.